Order Article Reprints

Shakerdi AL, Finnegan E, Sheng Y-Y, Vidovic K, Logan JM, Ward MP, O’Toole SA, Martin C, Selemidis S, Brooks D, et al. Crosstalk Between Inflammasome Signalling and Epithelial-Mesenchymal Transition in Cancer and Benign Disease: Mechanistic Insights, Context-Dependence, and Therapeutic Opportunities. Cells. 2025; 14(20):1594. https://doi.org/10.3390/cells14201594

Shakerdi, Abdul L., Emma Finnegan, Yin-Yin Sheng, Karlo Vidovic, Jessica M. Logan, Mark P. Ward, Sharon A. O’Toole, Cara Martin, Stavros Selemidis, Doug Brooks, and et al. 2025. "Crosstalk Between Inflammasome Signalling and Epithelial-Mesenchymal Transition in Cancer and Benign Disease: Mechanistic Insights, Context-Dependence, and Therapeutic Opportunities" Cells 14, no. 20: 1594. https://doi.org/10.3390/cells14201594

Shakerdi, A. L., Finnegan, E., Sheng, Y.-Y., Vidovic, K., Logan, J. M., Ward, M. P., O’Toole, S. A., Martin, C., Selemidis, S., Brooks, D., O’Leary, J. J., & Tewari, P. (2025). Crosstalk Between Inflammasome Signalling and Epithelial-Mesenchymal Transition in Cancer and Benign Disease: Mechanistic Insights, Context-Dependence, and Therapeutic Opportunities. Cells, 14(20), 1594. https://doi.org/10.3390/cells14201594